Effect of sphingomyelinase treatment on ligand binding activity of human serotonin1A receptors

被引:30
作者
Jafurulla, Md. [1 ]
Pucadyil, Thomas J. [1 ]
Chattopadhyay, Amitabha [1 ]
机构
[1] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 2008年 / 1778卷 / 10期
关键词
Serotonin(1A) receptor; Sphingomyelin; Sphingomyelinase; Ligand binding activity; Fluorescence anisotropy;
D O I
10.1016/j.bbamem.2008.07.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The serotonin(1A) receptor is an important member of the G-protein coupled receptor family, and is involved in the generation and modulation of a variety of cognitive, behavioral, and developmental functions. We have monitored the ligand binding of the human serotonin(1A) receptor stably expressed in CHO cells (termed CHO-5-HT1AR) following treatment with sphingomyelinase (SMase), an enzyme that specifically catalyzes the hydrolysis of sphingomyelin into ceramide and phosphorylcholine. Our results show, for the first time, that the specific ligand binding activity of the serotonin(1A) receptor in membranes isolated from CHO-5-HT1AR cells is increased upon sphingomyelinase treatment. Saturation binding analysis reveals increase in binding affinity of the receptor under these conditions. This is accompanied by a reduction in membrane order, as monitored by fluorescence anisotropy of the membrane probe 1-[4-(trimethylammonio)phenyl]-6-phenyl-1,3,5-hexatriene (TMA-DPH) in intact cells. These results represent the first report on the effect of sphingomyelinase treatment on the ligand binding activity of this important neurotransmitter receptor. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:2022 / 2025
页数:4
相关论文
共 32 条
[1]   CURRENT ADVANCES AND TRENDS IN THE TREATMENT OF DEPRESSION [J].
BLIER, P ;
DEMONTIGNY, C .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (07) :220-226
[2]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[3]  
Brown RE, 1998, J CELL SCI, V111, P1
[4]   Neutral sphingomyelinase: past, present and future [J].
Chatterjee, S .
CHEMISTRY AND PHYSICS OF LIPIDS, 1999, 102 (1-2) :79-96
[5]   Sphingolipids in apoptosis, survival and regeneration in the nervous system [J].
de Chaves, Elena I. Posse .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (12) :1995-2015
[6]   Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice [J].
Gingrich, JA ;
Hen, R .
PSYCHOPHARMACOLOGY, 2001, 155 (01) :1-10
[7]   Sphingomyelinases:: enzymology and membrane activity [J].
Goñi, FM ;
Alonso, A .
FEBS LETTERS, 2002, 531 (01) :38-46
[8]   5-HT1A receptor blockers as potential drug candidates for the treatment of anxiety disorders [J].
Griebel, G .
DRUG NEWS & PERSPECTIVES, 1999, 12 (08) :484-490
[9]   The organizing potential of sphingolipids in intracellular membrane transport [J].
Holthuis, JCM ;
Pomorski, T ;
Raggers, RJ ;
Sprong, H ;
Van Meer, G .
PHYSIOLOGICAL REVIEWS, 2001, 81 (04) :1689-1723
[10]   ROLE FOR CERAMIDE IN CELL-CYCLE ARREST [J].
JAYADEV, S ;
LIU, B ;
BIELAWSKA, AE ;
LEE, JY ;
NAZAIRE, F ;
PUSHKAREVA, MY ;
OBEID, LM ;
HANNUN, YA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (05) :2047-2052